Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PE/CA-PJ15 | 1 | | 1071 | 1025 | 12 | 2 | 32 | 95.71 | 1.31 | 2.99 | 6 | C14 | N | ||
| PE/CA-PJ15 | 2 | | 2102 | 1982 | 44 | 0 | 76 | 94.29 | 2.09 | 3.62 | 6 | C14 | N | ||
| PE/CA-PJ15 | 3 | | 3486 | 3264 | 81 | 0 | 141 | 93.63 | 2.32 | 4.04 | 6 | C14 | N | ||
| Tozasertib | PE/CA-PJ15 | 11.11 | 1 | | 623 | 591 | 12 | 7 | 13 | 94.86 | 3.05 | 2.09 | 6 | C15 | |
| Tozasertib | PE/CA-PJ15 | 11.11 | 2 | | 645 | 559 | 21 | 64 | 1 | 86.67 | 13.18 | 0.16 | 6 | C15 | |
| Tozasertib | PE/CA-PJ15 | 11.11 | 3 | | 770 | 697 | 36 | 20 | 17 | 90.52 | 7.27 | 2.21 | 6 | C15 | |
| GSK1070916 | PE/CA-PJ15 | 11.11 | 1 | | 698 | 652 | 12 | 3 | 31 | 93.41 | 2.15 | 4.44 | 6 | C16 | |
| GSK1070916 | PE/CA-PJ15 | 11.11 | 2 | | 791 | 706 | 70 | 5 | 10 | 89.25 | 9.48 | 1.26 | 6 | C16 | |
| GSK1070916 | PE/CA-PJ15 | 11.11 | 3 | | 834 | 663 | 153 | 0 | 18 | 79.50 | 18.35 | 2.16 | 6 | C16 | |
| Tozasertib | PE/CA-PJ15 | 0.015 | 1 | | 1057 | 1003 | 19 | 3 | 32 | 94.89 | 2.08 | 3.03 | 6 | C17 | |
| Tozasertib | PE/CA-PJ15 | 0.015 | 2 | | 1870 | 1784 | 29 | 0 | 57 | 95.40 | 1.55 | 3.05 | 6 | C17 | |
| Tozasertib | PE/CA-PJ15 | 0.015 | 3 | | 3220 | 3064 | 42 | 0 | 114 | 95.16 | 1.30 | 3.54 | 6 | C17 | |
| GSK1070916 | PE/CA-PJ15 | 11.11 | 1 | | 642 | 597 | 5 | 3 | 37 | 92.99 | 1.25 | 5.76 | 6 | C18 | |
| GSK1070916 | PE/CA-PJ15 | 11.11 | 2 | | 841 | 746 | 60 | 17 | 18 | 88.70 | 9.16 | 2.14 | 6 | C18 | |
| GSK1070916 | PE/CA-PJ15 | 11.11 | 3 | | 749 | 660 | 81 | 0 | 8 | 88.12 | 10.81 | 1.07 | 6 | C18 | |
| Tozasertib | PE/CA-PJ15 | 0.015 | 1 | | 996 | 933 | 16 | 4 | 43 | 93.68 | 2.01 | 4.32 | 6 | C19 | |
| Tozasertib | PE/CA-PJ15 | 0.015 | 2 | | 2088 | 1955 | 52 | 0 | 81 | 93.63 | 2.49 | 3.88 | 6 | C19 | |
| Tozasertib | PE/CA-PJ15 | 0.015 | 3 | | 3398 | 3231 | 54 | 0 | 113 | 95.09 | 1.59 | 3.33 | 6 | C19 | |
| GSK1070916 | PE/CA-PJ15 | 0.015 | 1 | | 943 | 889 | 20 | 1 | 33 | 94.27 | 2.23 | 3.50 | 6 | C20 | |
| GSK1070916 | PE/CA-PJ15 | 0.015 | 2 | | 1719 | 1601 | 51 | 12 | 55 | 93.14 | 3.66 | 3.20 | 6 | C20 | |
| GSK1070916 | PE/CA-PJ15 | 0.015 | 3 | | 2679 | 2523 | 76 | 0 | 80 | 94.18 | 2.84 | 2.99 | 6 | C20 | |
| PE/CA-PJ15 | 1 | | 992 | 930 | 28 | 5 | 29 | 93.75 | 3.33 | 2.92 | 6 | C21 | N | ||
| PE/CA-PJ15 | 2 | | 2186 | 2104 | 28 | 0 | 54 | 96.25 | 1.28 | 2.47 | 6 | C21 | N | ||
| PE/CA-PJ15 | 3 | | 3458 | 3286 | 57 | 0 | 115 | 95.03 | 1.65 | 3.33 | 6 | C21 | N | ||
| GSK1070916 | PE/CA-PJ15 | 0.015 | 1 | | 963 | 902 | 34 | 8 | 19 | 93.67 | 4.36 | 1.97 | 6 | C22 |